AC Immune SA is a clinical-stage biopharmaceutical company focused on precision medicine for neurodegenerative diseases. AC Immune SA develops therapeutic and diagnostic products designed to address disorders linked to protein misfolding, with a current emphasis on Alzheimer’s disease, Parkinson’s disease, ALS, and selected rare neurodegenerative conditions. Its work centers on proprietary technology platforms that support the discovery of antibodies, small molecules, vaccines, and imaging agents intended for early detection, treatment, and prevention. The company’s pipeline spans both therapeutic and diagnostic programs, reflecting a dual approach to understanding disease biology and creating targeted interventions. AC Immune SA also collaborates with pharmaceutical and research partners to advance its programs across neurodegenerative markets. Headquartered in Lausanne, Switzerland, AC Immune SA plays a specialized role in the biotechnology sector by developing tools and treatments aimed at some of the most complex and underserved diseases of the nervous system.
WebsiteBuilding B
Lausanne, 1015
Switzerland
AC Immune reported positive safety and immunogenicity results from Part 1 of its Phase 2 Parkinson's disease trial for ACI-7104.
Investors talking about ACIU also mention
What share of all stock conversation is about ACIU?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% new | 0% +0 | 0% 0 |
Of the messages about ACIU that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | 100% | 100% 0 | 91.77% -5.85 | ||
| Bearish | — | 0% | 0% 0 | 8.23% +5.85 |
Of the messages about ACIU that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | 100% | 100% | 51.78% | ||
| Controversies | — | 0% | 0% | 2.57% | ||
| Analysts | — | 0% | 0% | 7.56% | ||
| Earnings | — | 0% | 0% | 2% | ||
| Macro | — | 0% | 0% | 17.69% | ||
| Technical Analysis | — | 0% | 0% | 18.4% |
Of the messages about ACIU, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | 34.45% | 32.03% | 39.61% | ||
| Newcomers | — | 65.55% | 67.97% | 60.39% |